In another larger study that included ovarian clear cell carcinoma and endometrioid carcinoma, it was also demonstrated that a majority of samples that exhibited ARID1A mutations had a correlative absence of protein staining; however, there were samples with no mutations and no protein expression, corroborating the previous study [27]. This evidence concerns the gene ARID1A and ovarian clear cell cancer.